Progress of solute carrier SLC family in nonalcoholic fatty liver diseaseChinese Full TextEnglish Full Text (MT)
Zhiquan Tang;Li Shi;Jing Xiong;School of Pharmacy,China Pharmaceutical University;
Abstract: Nonalcoholic fatty liver disease is closely related to obesity and type 2 diabetes mellitus, and is one of the components of metabolic syndrome. Due to the complexity of its pathogenesis, there is no effective drug treatment to date. Solute carrier transporters are associated with a variety of metabolic diseases and are abundantly expressed in the liver. They participate in the transport of a variety of nutrients and metabolites, regulate nutrient supply, metabolic transformation, energy balance and oxidative stress, and modulate the physiological functions of liver. Particularly, it is important that some of these SLC transporters have become new targets for drug development. In this review, we summarize the role of SLC in the transport of nutrients and liver metabolites and its correlation with NAFLD, and reveal the potential of SLC as a target for the development of new drugs for NAFLD treatment so as to provide a new choice for the treatment of the disease.
- DOI:
10.16288/j.yczz.22-238
- Series:
(A) Mathematics/ Physics/ Mechanics/ Astronomy; (E) Medicine & Public Health
- Subject:
Digestive System Disease
- Classification Code:
R575.5
- Mobile Reading
Read on your phone instantly
Step 1Scan QR Codes
"Mobile CNKI-CNKI Express" App
Step 2Open“CNKI Express”
and click the scan icon in the upper left corner of the homepage.
Step 3Scan QR Codes
Read this article on your phone.
- HTML
- BETABETAEnglish HTML (MT)
- CAJ Download
- PDF Download
Download the mobile appuse the app to scan this coderead the article.
Tips: Please download CAJViewer to view CAJ format full text.
Download: 451 Page: 881-898 Pagecount: 18 Size: 681K
Citation Network
Related Literature
- Similar Article
- Reader Recommendation
- Associated Author